The most recently added documents are listed below. To narrow down the results into the key area you are interested in, select the relevant term and press search. You can narrow the results further by selecting more terms. Untick a selected box to remove that filter or click reset to start over.
This journal assess the Global Trachoma Mapping Project and concludes that it is possible to quality control and quality assure prevalence surveys in such a way as to maximize comparability of prevalence estimates between countries and permit high-speed, high-fidelity data processing and storage, while protecting the interests of health ministries.
This report aims to equip practitioners with an understanding of human rights, how human rights abuses cause and result from neglected diseases, and how a human rights approach can contribute to the fight against neglected diseases.
This study analyses an index focused on coverage of services for NTDs, comparable in methods to the UHC service coverage index.
This study aims to identify determinants for not utilizing TT surgery among TT patients in Mehalsayint District, North East Ethiopia.
The trachoma community undertook a systematic, three-pronged strategy to map trachoma district by district, develop national-level trachoma elimination plans, and create a framework for governments, donors and partners to convene and coordinate in support of trachoma elimination.
To facilitate planning for the elimination of trachoma as a public health problem, national trachoma surveys were conducted between 2011 and 2016 to determine the prevalence of trachomatous inflammation—follicular (TF) and trachomatous trichiasis (TT) in all 31 endemic HDs.
This study set out to determine major decision-making factors at the time of refusal. In addition, this study looked for ways to help increase surgical uptake by targeting modifiable factors.
The study demonstrates that in Malawi districts with TF of 5.0–9.9%, one round of azithromycin MDA with 80% coverage associates with a reduction in TF prevalence to <5%.